Last reviewed · How we verify

Kenalog (triamcinolone) — Competitive Intelligence Brief

Kenalog (triamcinolone) (Kenalog (triamcinolone)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology, Rheumatology, Dermatology, Endocrinology.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor Immunology, Rheumatology, Dermatology, Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Kenalog (triamcinolone) (Kenalog (triamcinolone)) — Walter Reed National Military Medical Center. Triamcinolone is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Kenalog (triamcinolone) TARGET Kenalog (triamcinolone) Walter Reed National Military Medical Center marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
Durezol DIFLUPREDNATE Novartis marketed difluprednate Glucocorticoid receptor 2008-01-01
Arnuity Ellipta FLUTICASONE FUROATE Haleon Us Holdings marketed Corticosteroid Glucocorticoid receptor 2007-01-01
Omnaris Alvesco Takeda Gmbh marketed ciclesonide Glucocorticoid receptor 2006-01-01
Omnaris CICLESONIDE Covis marketed ciclesonide Glucocorticoid receptor 2006-01-01
Mifeprex MIFEPRISTONE Corcept Therap marketed Progestin Antagonist [EPC] Glucocorticoid receptor 2000-01-01
Lotemax LOTEPREDNOL ETABONATE Bausch Health marketed Corticosteroid Glucocorticoid receptor 1998-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Kenalog (triamcinolone) — Competitive Intelligence Brief. https://druglandscape.com/ci/kenalog-triamcinolone. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: